Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Habel

Showing results (101-110 of 262) with videos related to

Pageof 27
Sort By:
Obstetrics and Gynecology|January 28, 2014
Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomyJohn K Chan, Renata Urban, Angela M Capra, et al.
Epidemiology (Cambridge, Mass.)|September 8, 2020
Risk of Renal Cell Carcinoma Associated with Calcium Channel Blockers: A Nationwide Observational Study Focusing on Confounding by IndicationKasper Bruun Kristensen, Laurel A Habel, Joshua J Gagne, et al.
Pharmacoepidemiology and Drug Safety|December 7, 2011
Risk of cancer in patients exposed to gabapentin in two electronic medical record systemsMichael C Irizarry, David J Webb, Nada Boudiaf, et al.
JAMA|July 12, 1995
Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged womenJ L Stanford, N S Weiss, L F Voigt, et al.
Sexually Transmitted Diseases|July 15, 1998
Risk factors for incident and recurrent condylomata acuminata among men. A population-based studyS K Van Den Eeden, L A Habel, K J Sherman, et al.
Sexually Transmitted Diseases|July 15, 1998
Risk factors for incident and recurrent condylomata acuminata among women. A population-based studyL A Habel, S K Van Den Eeden, K J Sherman, et al.
Archives of Pediatrics & Adolescent Medicine|October 5, 2006
Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicityG Thomas Ray, Peter Levine, Lisa A Croen, et al.
The American Journal of Managed Care|June 9, 2016
Breast cancer multigene testing trends and impact on chemotherapy useG Thomas Ray, Jeanne Mandelblatt, Laurel A Habel, et al.
Cancer Causes & Control : CCC|February 11, 2018
Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?Nancy Krieger, Sheida Nabavi, Pamela D Waterman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 9, 2010
Mammographic density and risk of second breast cancer after ductal carcinoma in situLaurel A Habel, Angela M Capra, Ninah S Achacoso, et al.
Pageof 27

Showing results (101-110 of 262) with videos related to

Sort By:
Pageof 27
Obstetrics and Gynecology|January 28, 2014
Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomyJohn K Chan, Renata Urban, Angela M Capra, et al.
Epidemiology (Cambridge, Mass.)|September 8, 2020
Risk of Renal Cell Carcinoma Associated with Calcium Channel Blockers: A Nationwide Observational Study Focusing on Confounding by IndicationKasper Bruun Kristensen, Laurel A Habel, Joshua J Gagne, et al.
Pharmacoepidemiology and Drug Safety|December 7, 2011
Risk of cancer in patients exposed to gabapentin in two electronic medical record systemsMichael C Irizarry, David J Webb, Nada Boudiaf, et al.
JAMA|July 12, 1995
Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged womenJ L Stanford, N S Weiss, L F Voigt, et al.
Sexually Transmitted Diseases|July 15, 1998
Risk factors for incident and recurrent condylomata acuminata among men. A population-based studyS K Van Den Eeden, L A Habel, K J Sherman, et al.
Sexually Transmitted Diseases|July 15, 1998
Risk factors for incident and recurrent condylomata acuminata among women. A population-based studyL A Habel, S K Van Den Eeden, K J Sherman, et al.
Archives of Pediatrics & Adolescent Medicine|October 5, 2006
Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicityG Thomas Ray, Peter Levine, Lisa A Croen, et al.
The American Journal of Managed Care|June 9, 2016
Breast cancer multigene testing trends and impact on chemotherapy useG Thomas Ray, Jeanne Mandelblatt, Laurel A Habel, et al.
Cancer Causes & Control : CCC|February 11, 2018
Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?Nancy Krieger, Sheida Nabavi, Pamela D Waterman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 9, 2010
Mammographic density and risk of second breast cancer after ductal carcinoma in situLaurel A Habel, Angela M Capra, Ninah S Achacoso, et al.
Pageof 27